News


<< Back
Share
 Print

Board changes and a new Chair announced for 2023

OMIC will be without the incredible talents of several Board and Committee members whose terms expire at the close of 2022. 

Dr. Denise Chamblee distinguished herself as one of the most influential Board members in recent memory, serving on the Executive Committee and chairing the Risk Management and Nominating Committees. 

Dr. Bradley Fouraker similarly impacted OMIC as one of the most active voices on OMIC’s Board for more than fifteen years. His advocacy in both his home state of Florida and nationally has won him accolades among his peers at both OMIC and the American Academy of Ophthalmology. 

Dr. Pauline Merrill has contributed extensively and fiercely defended the interests of ophthalmology throughout her tenure at OMIC. Drs. Chamblee, Fouraker, and Merrill will be profoundly missed. 

Finally, we extend our heartfelt gratitude to Drs. Ho Sun Choi and Michelle Ying for their years of service on OMIC Committees. 

Dr. Robert Gold of Maitland, Florida will assume leadership of OMIC  in 2023

We are pleased to announce that Dr. Robert Gold of Maitland, Florida, has been elected Chair of the OMIC Board of Directors beginning 1/1/2023. Learn more about Dr. Gold here.

 

Please refer to OMIC's Copyright and Disclaimer regarding the contents on this website

Leave a comment



Six reasons OMIC is the best choice for ophthalmologists in America.

Consistent return of premium.

Publicly-traded insurance companies exist to make profits for shareholders while physician-owned carriers often return profits to their policyholders. Don’t underestimate this benefit; it can add up to tens of thousands of dollars over the course of your career. OMIC has one of the most generous dividend programs for ophthalmologists and has returned more than $90 Million to our members through dividends.

61864684